Intralesional Interferon alpha-2b in the Treatment of Basal Cell Carcinoma and Squamous Cell Carcinoma: Revisited
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Dermatology,General Medicine,Surgery
Reference29 articles.
1. Virus interference. I. The interferon
2. Intralesional interferon therapy for basal cell carcinoma
3. Intralesional interferon alfa-2b in the treatment of basal cell carcinoma
4. Regional and intralesional treatment of invasive basal cell carcinoma with interferon alfa-n2b
5. Treatment of cutaneous squamous cell carcinomas by intralesional interferon alfa-2b therapy
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunity against Non-Melanoma Skin Cancer and the Effect of Immunosuppressive Medication on Non-Melanoma Skin Cancer Risk in Solid Organ Transplant Recipients;Cells;2023-10-11
2. Treatment of basal cell carcinoma with intralesional interferon alfa-2b: an open-label clinical trial;Expert Review of Anticancer Therapy;2023-06-05
3. Successful management of hydroxyurea‐induced multiple actinic keratoses and cutaneous squamous cell carcinomas with combination treatment;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-02
4. Erfolgreiche Behandlung Hydroxyharnstoff‐induzierter multipler aktinischer Keratosen und kutaner Plattenepithelkarzinome mit einer Kombinationstherapie;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-02
5. Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient;Frontiers in Immunology;2021-05-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3